ArticleScientific reports2025
A bias-resilient client selection analysis for federated brain tumor segmentation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Are AI Neuroimaging Models Ready for Clinical Use? A Systematic Methodological Review.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumor segmentation is difficult because of a number of technical problems, including its complex morphology, individual differences in anatomy, irregular shapes, overlapping, homogeneous gray matter and white matter intensity values, abnormalities that might not contrast with normal tissues, and the possibility of additional complications from various modalities. Expert radiologists may make different conclusions as a result of these difficulties. Regarding this, deep learning techniques, particularly CNN models, can be trained to handle these MRI artifacts and automatically extract features that the human eye is unable to detect, such as variations in shape, texture, and color. Deep learning models may effectively learn features across various modalities, but they are data-hungry techniques that could be enhanced with additional annotated data. Yet, data privacy is the main barrier to the real use of data centralization. To deal with these challenges proposed a federated learning approach. The proposed federated learning enables the decentralized learning of a shared model while sharing data. However, the traditional paradigm introduced in the literature involves institutional biases that have an impact on distributed learning. Proposed Fed_WCE_BTD (Federated Learning with Weak Client Elimination for Brain Tumor Detection) is a combination of a modified UNet architecture and federated. In addition, proposed method uses an optimal adaptive client selection strategy by carefully choosing each client based on their unique strengths. Our contribution to this crucial and costly diagnostic is being validated using the BRATS 2021 dataset, taking into account the slicing of brain tumors. The goal of this research is to outperform non-federated learning or perform on par with non-federated environments. At present, the suggested model is outperforming the others by 1% for detection of enhancing tumor and necrosis. The efficiency of the proposed federated learning was demonstrated by considerably higher dice-coefficient of enhancing tumor (p< 0.05) as compared to non-federated learning. However, the edema identification dice coefficient is 80%, which is similar to the baseline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.